BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
search help

Documents 1-9 out of 9 found
  Current Search:  wydase: 12, hyaluronidase: 134  

100%
TEXT
http://www.fda.gov/cder/orange/appendix_a.txt
4, ACETAMINOPHEN TYLENOL W/ CODEINE, ACETAMINOPHEN TYLENOL, ACETAMINOPHEN (OTC) TYLOX, ACETAMINOPHEN TYLOX-325, ACETAMINOPHEN TYMTRAN, CERULETIDE DIETHYLAMINE TYZINE, TETRAHYDROZOLINE HYDROCHLORIDE TZ-3, TIOCONAZOLE (OTC) ** U ** U-CORT, HYDROCORTISONE ACETATE U-GENCIN, GENTAMICIN SULFATE UCEPHAN, SODIUM BENZOATE ULO, CHLOPHEDIANOL HYDROCHLORIDE ULTANE, SEVOFLURANE ULTIVA,...

Matching: wydase hyaluronidase Find similar documents More document info
100%
HTML
Prescription and Over-the-Counter Drug Product List: 8/2003
4 >D> AA + ORTHO MCNEIL PHARM 300MG;60MG N85055 004 AUG DISC >A> @ 300MG;60MG N85055 004 AUG DISC ACETAMINOPHEN; HYDROCODONE BITARTRATE SOLUTION; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >A> AA + MALLINCKRODT 500MG/15ML;10MG/15ML N40508 001 AUG 29, 2003 AUG NEWA >D> MIKART 500MG/15ML;5MG/15ML N81226 001 OCT 27, 1992 AUG CTEC >A> AA 500MG/15ML;5MG/15ML N81226 001 OCT 27, 1992 AUG...
author: AUTHOR
Matching: wydase hyaluronidase Find similar documents More document info
100%
HTML
Reference Listed Drug Labeling Approved in April 2000
Tradename Active Ingredient(s) / Dosage Form NDA/Sup# Firm April AMICAR Aminocaproic acid INJ 15-229 030 Immunex 3 AMICAR Aminocaproic acid TAB 15-197 034 Immunex 3 LO/OVRAL Norgestrel/ethinyl estradiol TAB 17-612 031 Wyeth Ayerst 3 NORDETTE-21 Levonorgestrel/ethinyl estradiol TAB 18-668 030 Wyeth Ayerst 3 PREVEN Levonorgestrel/ ethinyl estradiol TAB 20-946 005 Gynetics 3 CALCIJEX...
author: GraceJ
Matching: wydase hyaluronidase Find similar documents More document info
100%
HTML
Prescription and OTC Drug Product List 7/2001
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE TABLET; ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE -A- AB ABLE 325MG;50MG;40MG N40390 001 JUL 23, 2001 JUL NEWA -A- AB 500MG;50MG;40MG N40394 001 JUL 23, 2001 JUL NEWA ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN -D- AA + WATSON LABS 325MG;7.5MG...
Matching: wydase hyaluronidase Find similar documents More document info
55%
HTML
What's new at CDER in the last 30 days
(2/20/2004) About CDER CDER Key Officials (Updated 1/ 13 /200 4) CDER Organization Charts Center for Drug Evaluation Research Organizational Chart (Updated 2/27/2004) Office of Center Director (Updated 2/27/2004) Office of Management (Updated 2/27/2004) Office of Pharmaceutical Sciences (Updated 2/27/2004) Office of Pharmacoepidemiology and Statistical Science - (Updated 2/27/2004)...
author: Paul Stauffer
Matching: wydase Find similar documents More document info
55%
HTML
What's new at CDER by Date
MedWatch Safety Information Draft Guidance: Providing Regulatory Submissions in Electronic Format - Content of Labeling [ Word ] or [ PDF ] Inactive Ingredient Database (updated) Orange Book Query January 30, 2004 Approval Times for Priority and Standard NDAs - Calendar Years 1993-2003 (updated) Consumer Drug Information Sheets Cialis Drug Shortages Current Drug Shortages : Solu...
author: Paul Stauffer
Matching: wydase Find similar documents More document info
55%
HTML
Drug Shortages
FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - - Drug Shortages - Introduction FAQs Current Drug Shortages - Resolved Drug Shortages Drugs to be Discontinued - Drug Shortage Manual of Policies and Procedures (MaPP) Medical Necessity Guidance Document How to Report a Drug Shortage - Practical Steps for Practitioners Facing Shortage...
Matching: Find similar documents More document info
55%
PDF
ltcp0101.pdf
Clinical Pearls from Continuing Care Rounds January 2001 Hydration and Palliative Care Dr Eric Wasylenko · Palliative patients are at risk of dehydration due to profound anorexia, odynophagia, dysphagia, early satiety, oral cavity lesions, nausea/ vomiting & cognitive impairment
· Artificial rehydration can lead to symptoms from third spacing ;such as worsened peripheral...

author: FMurray
Matching: wydase Find similar documents More document info

55%
PDF
ltcp0101.pdf page 1


author: FMurray
Matching: wydase Find similar documents More document info


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.